Schwartz Michael D, Emerson Stephen G, Punt Jennifer, Goff Willow D
1Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
2Immunology and Medicine, Columbia University, New York, NY 10027, USA.
Aging Dis. 2020 Jul 23;11(4):742-745. doi: 10.14336/AD.2020.0619. eCollection 2020 Jul.
Aging, type 2 diabetes, and male gender are major risk factors leading to increased COVID-19 morbidity and mortality. Thymic production and the export of naïve T cells decrease with aging through the effects of androgens in males and in type 2 diabetes. Furthermore, with aging, recovery of naïve T-cell populations after bone marrow transplantation is delayed and associated with an increased risk of chronic graft vs. host disease. Severe COVID-19 and SARS infections are notable for severe T-cell depletion. In COVID-19, there is unique suppression of interferon signaling by infected respiratory tract cells with intact cytokine signaling. A decreased naïve T-cell response likely contributes to an excessive inflammatory response and increases the odds of a cytokine storm. Treatments that improve naïve T-cell production may prove to be vital COVID-19 therapies, especially for these high-risk groups.
衰老、2型糖尿病和男性性别是导致COVID-19发病率和死亡率增加的主要风险因素。随着年龄增长,胸腺产生和幼稚T细胞输出会因男性和2型糖尿病中雄激素的作用而减少。此外,随着年龄增长,骨髓移植后幼稚T细胞群体的恢复会延迟,并与慢性移植物抗宿主病风险增加相关。严重的COVID-19和SARS感染以严重的T细胞耗竭为特征。在COVID-19中,受感染的呼吸道细胞对干扰素信号传导有独特的抑制作用,而细胞因子信号传导保持完整。幼稚T细胞反应降低可能导致过度炎症反应,并增加细胞因子风暴的几率。改善幼稚T细胞产生的治疗方法可能被证明是至关重要的COVID-19治疗方法,尤其是对这些高危人群。